ArticleCardiovascular drugs and therapy2023

Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality Analysis.

Amandine Gouverneur et al.PubMed ↗Publisher ↗

No numbers read from the abstract.